The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.
----------
SMALL-CAP - WINNERS
----------
Roquefort Therapeutics PLC, up 54% at 2.38 pence, 12-month range 1.40p-8.30p. The biotechnology firm signs a term sheet for the proposed sale of Oncogeni Ltd to Nations Trust Holding LLC for $12 million. ‘The proposed sale of Oncogeni is an important step towards completing the initial phase of the company’s strategy to acquire and develop pre-clinical assets and to then realise value through completing trade-sale transactions. We are pleased to be working with such a well-funded and highly resourced partner to take the Oncogeni portfolio into clinical trials, which if successful, will create long term value for the company,’ Chief Executive Officer Ajan Reginald says.
----------
SMALL-CAP - LOSERS
----------
Capital Ltd, down 18% at 63.00p, 12-month range 59.40p-105.61p. The mining services provider says it expects to report a decline in profit, as it books non-cash provisions for 2024 relating to historical VAT receivables and various laboratory assets in Mali. In addition, it says its chief executive has tendered his resignation. It now predicts a net profit after tax in the range of $18 million and $20 million, a decline of up to 53% from $38.5 million reported for 2023. For this year, it predicts revenue in the range of $300 million and $320 million. ‘Revenues will be H2 weighted given the ramp up of new projects, predominantly in our mining business, and margins will follow a similar weighting,’ it adds. Capital has accepted the resignation of CEO Peter Stokes. Stokes will stick around for a ‘brief transitional period’.
----------
SIG PLC, down 2.3% at 12.90p, 12-month range 11.06p-31.00p. RBC cuts its price target for the building products supplier to 16p from 22p. It rates SIG at ’sector perform’.
----------
Copyright 2025 Alliance News Ltd. All Rights Reserved.
